Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update - Concepedia

Concepedia

Publication | Open Access

Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update

DOI Full Paper Access

44

Citations

26

References

2021

Year

Timothy P. Hughes, Nelma Cristina D. Clementino, Mikhail Fominykh, Jeffrey H. Lipton, Anna Turkina, Elena Beatriz Moiraghi, Franck E. Nicolini, Naoto Takahashi, Tomasz Sacha, Dong‐Wook Kim,

Hematological MalignancyChronic Myeloid LeukemiaOncologyMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaPharmacotherapySecond-line NilotinibMedicineRadiation OncologyCancer ResearchLong-term Treatment-free RemissionHealth Sciences

References

	Year	Citations

Page 1

Page 1